The Anglo-Swedish Pharma giant AstraZeneca PLC (AZN) will share its Q3 2026 earnings and business updates on October 30th—analysts are expecting revenues of $16bn and GAAP earnings per share ("EPS") of $1.15, although we may
CryptoAlerta — análise de criptomoedas e mercado em tempo real